The Leipzig Interventional Course

LINC 2019

Booth # 13a

January 22 to 25, 2019

Trade Fair Leipzig, Hall 2

Messe-Allee 1, 04356 Leipzig, Germany

Philips is the leader in image-guided therapy, providing integrated solutions that advance minimally invasive procedures. We help healthcare providers to decide, guide, treat and confirm the right care in real time during the procedure to enable better outcomes for each patient and at population level.

Working together with clinicians, we use our comprehensive portfolio of interventional imaging systems, smart devices, software and services to treat one patient every second worldwide.

Together with health providers we optimize care delivery, reduce total costs, and help clinicians treat patients better so they can get back faster to the lives they love.

This year in Leipzig Philips will showcase unique position, as a global leader in interventional care. We are preparing gamechanging innovations in image guided therapy systems and devices. Stop by our booth 13a to get a demo session, and join us in extensive scientific program to learn more.

Philips Symposium

Tuesday, January 22nd, 9:30 - 11:00, Room 1 - Main Arena 1

See clearly, treat optimally: Image guided therapy on the rise

Supported with an educational grant from Philips

Moderators: D. Scheinert, F. Moll

Panel: C. Pena, J. Reekers, F. Fanelli, M. Izamis

Add to calendar

Topic	Time	Lecture Title	Speaker
Intro	5	Introduction & Learning Objectives	Dierk Scheinert
Next generation IGT suite & Clarity	14	Next generation pan-vascular suite: optimizing patient management and outcomes	Constantino Peña
2D Perfusion	8	Perfusion angiography for optimizing planning and treatment of diabetic foot	Jim A. Reekers
LIVE CASE #1	20	BTK recorded case presentation	Marco Manzi
IVUS	8	Role of IVUS within a "treat-optimally" algorithm of care	Fabrizio Fanelli
Various	10	Innovations at the forefront: a glance at the future of Image guided Therapy	Maria Louisa Izamis
LIVE CASE #2	20	SFA: Philips System + Phoenix or AngioSculpt or Laser + Stellarex from Leipzig
Closure	5	Q&A and Conclusions

Lectures to follow

Hear from the prominent experts on advancements in image guided therapy

Read the full program

Tuesday, January 22nd

	Room 1 – Main Arena 1

9:55 – 10:00	DCB in severe Calcium: Core-laboratory analysis and perspectives from the ILLUMINATE trial series J. Popma
10:00 – 10:05	Stellarex in real world: Interim look from the SAVER registry F. Vermassen
16:59 – 17:05	Role and benefit of IVUS in PAD revascularisation: results from an angio vs. IVUS randomized study I.Spark
17:21 – 17:27	From research to practice: how does atherectomy fit in my treatment algorithm G. Korosoglou
17:55 – 18:00	Phoenix atherectomy: technique and real-world evidence M. Montero-Baker

Wednesday, January 23rd

	Room 1 – Main Arena 1

12:11 – 12:16	Is non-functional microcirculation the same as flow-independent ischemia? J. Reekers
17:19 – 17:25	Combination therapy tackling ISR: laser + DCB 2-year results E. Armstrong
17:25 – 17:31	Advancing laser therapy: different settings for different lesion G. Adams

	Room 2 – Main Arena 2

09:15 – 09:21	Workflow innovation in the hybrid OR space H. Wendorff
09:21 – 09:27	Sterility in the hybrid OR – A crucial hygiene factor R. Traversari
09:27 – 09:33	Rationale for IVUS guided endovascular aortic repair J. Teßarek
9:33 – 09:39	First time data release: Innovation in 3D navigation: results from the FORS – Fibre Optic RealShape first in-human study J. van Herwaarden

	Room 5 – Global Expert Exchange Forum

08:10 – 08:25	Pre-clinical and histology findings from different DCBs R. Coscas
9:15 – 09:20	Cost economic evidence: what do DCB deserve? The US case example G. Adams
15:29 – 15:36	The VIDIO trial: diagnostic and clinical implications on the use of IVUS for deep venous treatment E. Murphy

Thursday, January 24th

	Room 1 – Main Arena 1

9:22 – 09:30	Prestige pilot: Phoenix atherectomy and Stellarex DCB in infrapopliteal interventions M. Lichtenberg
16:48 – 16:54	Perfusion angiography: towards new standards for optimized treatment outcomes D. van den Heuvel